Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Shawshank Redemption: “How can you be so obtuse?”
Warden Norton:” What? What did you call me?”
(Mild by your standard PL :-)
DG, he is indeed in a green box. It’s not effective sadly as thread after lengthy thread contains multiple reply posts starting with his name arguing against his posts that are therefore obviously moronic vacuous sea lion bait. He’s a scumbag so I like to remind everyone of that.
Of course he caveats all his chart garbage. They all do. Here you go, I can give you some insight now if you enjoy that sort of thing…
According to my chart there is support at 215p, if we fall beneath it, we’ll fall beneath it. There is resistance at 275p, so we might go above it. If we go above it, then we’ll be above it. If we stay above it then it might become support. In conclusion, I predict that the price will go up or down, but I’ll only say both so that I can say I’m correct no matter what. I’ll ignore the fundamentals as I only care about the chart. However, I’ll spout garbage constantly about the fundamentals as I’m a hypocritical sea lion and I think I can use it to my advantage by spreading fear doom and misery when I’m looking for an entry.
That the kind of thing you enjoy? I can start posting this nonsense of every single thread multiple times a day if it helps.
Investing in a company that has the opportunity (AVA) to add billions to the MCAP overnight is viewed as a bonus. It’s my main push :)
D-Geeman - TLDR; Wyn willl always offer a *might* caveat to TA predictions. It really isn’t clever.
Wyn is clearly not a stupid person. Far from it. But suggesting that his TA analysis is any more than fantasy is, folly.
WillHunt, you wrote:'Trusted the charts. The charts according to Wyn were pointing south this week. Then news moved it north. News has always controlled this stock. News made us drop. News. Not charts. News. This fella is ******* bonkers.’
Now, I am not especially bright – I get by – but even I can very easily understand what wyn has said and he never said what *would* happen based on the charts, just what was more likely than not based on herd instinct and how the herd usually deals with the situation as it was. I don't actually remember back more than a few posts but Wyn usually says *IF* this happens, then *that* might follow (based on herd behaviour).
(My interpretation of herd behaviour might be similar to saying 'If someone shouts 'fire' then the most likely crowd behaviour would be for people to run for the exits. Did I say there *would* be a person shouting 'Fire'? No I didn't. And if news breaks that a sprinkler system has just been finished then the herd behaviour might react to the news differently. And people here dispute that..)
Nor is it true to say, PL, that you haven't found his posts un-interesting; if you hadn't you wouldn't even have had a dialogue and you certainly wouldn't continue to be as gratuitously rude as you are – and I thought you saw green boxes when wyn writes anyway? If you're not interested, just ignore; it's SO simple.
Anyway, thankfully wyndrum is thick-skinned enough to carry on sharing his views on the charts and his own view of AVCT's prospects in this continuing pandemic.
I don't actually trade (wish I were lucky enough to be able to make the trades work). I top up on the dips and even some of the spikes so I'm not a user of 'the charts’ though, like everyone, I look at previous prices (doesn’t that mean everyone relies on TA to some extent?) To me, anyone here who ignores useful data in such an important area as buying a selling valuable chunks of stock reminds me of a line in the Shawshank Redemption. I'll save it for if I need it; see if you spot it.
The precision platform is more of a bonus product. Seriously. Complete f-wit
Another possible scenario ... sale of the diagnostics division so they can concentrate on the therapeutics?
Ndn - they’ll sell tests. Might not be 60m/month, but they’ll sell enough to underpin the SP.
The Ava stuff will be with us by the end of the year. You describe your investment as a punt.
If all that comes to fruition and there is no buy out on the way we will be up there as big Al said with the likes of Roche, and I guess that's why we are all here.
ND71 I agree, if even a few items of their pipeline deliver, the big pharmaceuticals will be after them. If that were the case hopefully £25+ a share buy then.
That was the obvious caveat that I thought about making, but decided to omit it.
Assuming...
So, the LFT sells a decent amount and the coffers are swelling. AVA6K passes phase 1 and 2 and becomes a drug of choice. Early phase 1 data suggests that the Pro-drug idea is a goer and Abakta use their LFT cash to accelerate the pipeline and we soon have various drugs of choice. Oh and why not? TMAC comes good and Affimers start to make inroads into the massice Ab market. All fanciful, but possible. Fingers crossed, eh?
At what point does Awacta start paying regular dividends?